Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2014-01-29 Board/Management Inform…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Directorate Change
Board/Management Information Classification · 99% confidence The document is identified by the RNS Number (7373Y) and the date (29 January 2014). The content explicitly announces a 'Directorate Change,' stating that Ed Torr is stepping down as an Executive Director. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and is a direct announcement, not a report itself.
2014-01-29 English
Statement re Trading Update and Notice of Results
Earnings Release Classification · 98% confidence The document is titled 'Trading Update' and provides unaudited highlights (revenue, operating profit estimates) ahead of the full half-year financial results announcement scheduled for a future date (February 25, 2014). It details performance for the period ended December 31, 2013. This structure—a brief, preliminary announcement of key financial figures before the comprehensive report—is characteristic of an Earnings Release (ER). Although it mentions the half-year period (which might suggest an Interim Report 'IR'), the content is a high-level summary ('Highlights') rather than the full, detailed financial statements typical of an IR. The presence of the RNS Number confirms it is a regulatory announcement, but the specific content points to ER. H1 2014
2014-01-13 English
Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is very short (1875 characters) and explicitly states it is providing information in conformity with DTR 5.6.1R, notifying the market of the total number of shares with voting rights (87,297,847). This is a standard regulatory disclosure regarding the total share capital denominator used for shareholder notification calculations under Disclosure and Transparency Rules. Since it is a specific, mandatory regulatory notification that doesn't fit the definitions for DIRS (Director's Dealing), SHA (Share Issue/Capital Change), or POS (Transaction in Own Shares), and it is not an announcement of a major report (RPA), the most appropriate classification is the general regulatory filing category, RNS (Regulatory Filings).
2013-12-31 English
Half-Yearly Financial Report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-Yearly Financial Report' for Dechra Pharmaceuticals PLC for the period ended 31 December 2013. It contains comprehensive financial statements (Income Statement, Statement of Financial Position, Cash Flows), notes to the financial statements, and an independent review report. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2014
2013-12-31 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is very short (1605 characters) and contains an RNS Number ('RNS Number : 9073V'). The content explicitly details a share transaction involving a Director/PDMR's spouse ('Director / PDMR shareholding') and the resulting shareholding percentage. This directly matches the definition of Director's Dealing (insider trades by executives/directors). Therefore, the appropriate code is DIRS.
2013-12-18 English
Director's Declaration
Board/Management Information Classification · 99% confidence The document is very short (1405 characters) and contains an RNS Number, indicating it is a regulatory announcement. The content explicitly states that a Senior Independent Non-Executive Director, Ishbel Macpherson, is being appointed as a Non-Executive Director of another company (Galliford Try PLC) effective February 1, 2014. This type of announcement concerns changes in the board of directors or senior management. This directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content points strongly to MANG over the general RNS fallback.
2013-12-18 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.